SKVI
Skinvisible, Inc.
Price Chart
Latest Quote
$0.21
+0.00 (+0.00%)
Current Price
| Previous Close | $0.21 |
| Open | $0.44 |
| Day High | $0.44 |
| Day Low | $0.44 |
| Volume | 10 |
Stock Information
| Shares Outstanding | 5.40M |
| Total Debt | $5.80M |
| Cash Equivalents | $2K |
| Revenue | $20K |
| Net Income | $-1.05M |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $1.15M |
| EPS (TTM) | $-0.20 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $6.94M |
| Sales | $20K |
| Income | $-1.05M |
| Book/sh | $-1.90 |
| Cash/sh | $0.00 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.01 |
Returns & Margins
| ROA | -224.19% |
| Gross Margin | 100.00% |
| Operating Margin | -2518.76% |
Ownership
| Insider Ownership | 3.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 1.94 |
| P/S | 57.44 |
| P/B | -0.11 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.21 |
| SMA50 | $0.23 |
| SMA200 | $0.32 |
| RSI | 52.96 |
| ATR | 0.0323 |
| Shares Float | 5.21M |
| Rel Volume | 0.00 |
Performance History
| Week | +0.00% |
| Month | +10.91% |
| Quarter | +1.19% |
| 6 Months | -50.20% |
| YTD | -7.81% |
| Year | +20.59% |
| 3 Years | +165.75% |
| 5 Years | +56.32% |
| 10 Years | +1.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $0.21 | 10 |
| 2026-06-12 | $0.21 | 0 |
| 2026-06-11 | $0.21 | 0 |
| 2026-06-10 | $0.21 | 0 |
| 2026-06-09 | $0.21 | 0 |
| 2026-06-08 | $0.21 | 0 |
| 2026-06-05 | $0.21 | 0 |
| 2026-06-04 | $0.21 | 0 |
| 2026-06-03 | $0.21 | 550 |
| 2026-06-02 | $0.20 | 1,500 |
| 2026-06-01 | $0.25 | 0 |
| 2026-05-29 | $0.25 | 2,044 |
| 2026-05-28 | $0.30 | 34,667 |
| 2026-05-27 | $0.20 | 0 |
| 2026-05-26 | $0.20 | 525 |
| 2026-05-22 | $0.17 | 0 |
| 2026-05-21 | $0.17 | 0 |
| 2026-05-20 | $0.17 | 0 |
| 2026-05-19 | $0.17 | 742 |
| 2026-05-18 | $0.19 | 0 |
About Skinvisible, Inc.
Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its flagship product, Invisicare, is a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. The company also offers non-dermatological formulations for women's health, pain management, and other markets. In addition, it engages in the development and licensing of topical prescription and over-the-counter products, as well as the co-development of formulations for pharmaceutical clients. Further, the company provides solutions to pharmaceutical companies by reformulating products coming off patent with a new Invisicare patent, and new product benefits and line extensions. It has a licensing and collaboration agreement with Ovation Science for the use of Invisicare technology with cannabinoids for topical/transdermal products, including new formulations with THC-V targeting obesity and metabolic health. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.
đ° Latest News
No news articles available at the moment. Check back later for updates on SKVI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $0 | $0 | $4,808 | $3,300 |
| Cost Of Revenue | $0 | $0 | $4,808 | $3,300 |
| Total Revenue | $20,000 | $20,000 | $279,296 | $663,426 |
| Operating Revenue | $20,000 | $20,000 | $279,296 | $663,426 |
| Expenses | ||||
| Interest Expense | $669,438 | $1,887,150 | $1,162,869 | $1,213,043 |
| Total Expenses | $609,589 | $510,375 | $517,728 | $475,346 |
| Other Income Expense | $693,373 | $-4,915 | $176,414 | $-47,790 |
| Net Non Operating Interest Income Expense | $-669,438 | $-1,887,150 | $-1,162,869 | $-1,213,043 |
| Interest Expense Non Operating | $669,438 | $1,887,150 | $1,162,869 | $1,213,043 |
| Operating Expense | $609,589 | $510,375 | $512,920 | $472,046 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Net Interest Income | $-669,438 | $-1,887,150 | $-1,162,869 | $-1,213,043 |
| Normalized Income | $-1,259,027 | $-2,377,525 | $-1,401,301 | $-1,024,963 |
| Net Income From Continuing And Discontinued Operation | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Total Operating Income As Reported | $-589,589 | $-490,375 | $-238,432 | $188,080 |
| Net Income Common Stockholders | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Net Income | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Net Income Including Noncontrolling Interests | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Net Income Continuous Operations | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Pretax Income | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Special Income Charges | $697,249 | $0 | $144,379 | $109,688 |
| Operating Income | $-589,589 | $-490,375 | $-238,432 | $188,080 |
| Depreciation Amortization Depletion Income Statement | $20,438 | $18,771 | $18,738 | $17,939 |
| Depreciation And Amortization In Income Statement | $20,438 | $18,771 | $18,738 | $17,939 |
| Gross Profit | $20,000 | $20,000 | $274,488 | $660,126 |
| Per Share | ||||
| Diluted EPS | $-0.11 | $-0.52 | $-0.27 | $-0.24 |
| Basic EPS | $-0.11 | $-0.52 | $-0.27 | $-0.24 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-569,151 | $-471,604 | $-219,694 | $206,019 |
| Total Unusual Items | $693,373 | $-4,915 | $176,414 | $-47,790 |
| Total Unusual Items Excluding Goodwill | $693,373 | $-4,915 | $176,414 | $-47,790 |
| Reconciled Depreciation | $20,438 | $18,771 | $18,738 | $17,939 |
| EBITDA (Bullshit earnings) | $124,222 | $-476,519 | $-43,280 | $158,229 |
| EBIT | $103,784 | $-495,290 | $-62,018 | $140,290 |
| Diluted Average Shares | $5,061,350 | $4,539,843 | $4,539,843 | $4,539,843 |
| Basic Average Shares | $5,061,350 | $4,539,843 | $4,539,843 | $4,539,843 |
| Diluted NI Availto Com Stockholders | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Other Special Charges | $-697,249 | - | $-144,379 | $-109,688 |
| Gain On Sale Of Security | $-3,876 | $-4,915 | $32,035 | $-157,478 |
| Selling General And Administration | $589,151 | $491,604 | $494,182 | $454,107 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-9,362,136 | $-9,150,452 | $-6,777,450 | $-5,568,771 |
| Total Assets | $158,217 | $162,869 | $246,793 | $227,299 |
| Total Non Current Assets | $116,189 | $127,409 | $136,847 | $153,055 |
| Goodwill And Other Intangible Assets | $116,189 | $127,409 | $136,847 | $153,055 |
| Other Intangible Assets | $116,189 | $127,409 | $136,847 | $153,055 |
| Current Assets | $42,028 | $35,460 | $109,946 | $74,244 |
| Other Current Assets | $9,100 | $7,980 | $9,495 | $8,125 |
| Receivables | $22,592 | $26,592 | $19,073 | $82 |
| Accounts Receivable | $5,000 | $5,000 | $5,000 | $82 |
| Cash Cash Equivalents And Short Term Investments | $10,336 | $888 | $81,378 | $66,037 |
| Cash And Cash Equivalents | $10,336 | $888 | $81,378 | $66,037 |
| Cash Financial | $10,336 | $888 | $81,378 | $66,037 |
| Prepaid Assets | - | - | - | $8,125 |
| Debt | ||||
| Net Debt | $5,727,506 | $6,152,217 | $3,634,632 | $3,016,586 |
| Total Debt | $5,737,842 | $6,153,105 | $3,716,010 | $3,082,623 |
| Long Term Debt And Capital Lease Obligation | $5,724,478 | $5,673,505 | $3,242,410 | $2,581,724 |
| Long Term Debt | $5,724,478 | $5,673,505 | $3,242,410 | $2,581,724 |
| Current Debt And Capital Lease Obligation | $13,364 | $479,600 | $473,600 | $500,899 |
| Current Debt | $13,364 | $479,600 | $473,600 | $500,899 |
| Other Current Borrowings | $13,364 | $46,000 | $40,000 | $67,299 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,404,164 | $9,185,912 | $6,887,396 | $5,643,015 |
| Total Non Current Liabilities Net Minority Interest | $5,724,478 | $5,673,505 | $3,242,410 | $2,581,722 |
| Current Liabilities | $3,679,686 | $3,512,407 | $3,644,986 | $3,061,293 |
| Other Current Liabilities | $22,420 | $18,544 | $13,629 | $45,666 |
| Current Notes Payable | $0 | $433,600 | $433,600 | $433,600 |
| Payables And Accrued Expenses | $3,643,902 | $3,014,263 | $3,157,757 | $2,514,728 |
| Interest Payable | $2,784,909 | $2,575,595 | $1,955,820 | $1,475,067 |
| Payables | $858,993 | $438,668 | $1,201,937 | $1,039,661 |
| Accounts Payable | $858,993 | $438,668 | $1,201,937 | $1,039,661 |
| Other Non Current Liabilities | - | - | - | $-2 |
| Equity | ||||
| Common Stock Equity | $-9,245,947 | $-9,023,043 | $-6,640,603 | $-5,415,716 |
| Total Equity Gross Minority Interest | $-9,245,947 | $-9,023,043 | $-6,640,603 | $-5,415,716 |
| Stockholders Equity | $-9,245,947 | $-9,023,043 | $-6,640,603 | $-5,415,716 |
| Other Equity Interest | $10,000 | - | - | - |
| Retained Earnings | $-39,946,142 | $-39,380,488 | $-36,998,048 | $-35,773,161 |
| Other | ||||
| Ordinary Shares Number | $5,316,843 | $4,539,843 | $4,539,843 | $4,539,843 |
| Share Issued | $5,316,843 | $4,539,843 | $4,539,843 | $4,539,843 |
| Tangible Book Value | $-9,362,136 | $-9,150,452 | $-6,777,450 | $-5,568,771 |
| Invested Capital | $-3,508,105 | $-2,869,938 | $-2,924,593 | $-2,333,093 |
| Working Capital | $-3,637,658 | $-3,476,947 | $-3,535,040 | $-2,987,049 |
| Total Capitalization | $-3,521,469 | $-3,349,538 | $-3,398,193 | $-2,833,992 |
| Additional Paid In Capital | $30,684,878 | $30,352,905 | $30,352,905 | $30,352,905 |
| Capital Stock | $5,317 | $4,540 | $4,540 | $4,540 |
| Common Stock | $5,317 | $4,540 | $4,540 | $4,540 |
| Current Accrued Expenses | $2,784,909 | $2,575,595 | $1,955,820 | $1,475,067 |
| Duefrom Related Parties Current | $17,592 | $21,592 | $14,073 | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-79,052 | $-86,490 | $42,640 | $353,741 |
| Operating Activities | ||||
| Operating Cash Flow | $-69,834 | $-77,157 | $45,170 | $374,605 |
| Cash Flow From Continuing Operating Activities | $-69,834 | $-77,157 | $45,170 | $374,605 |
| Operating Gains Losses | $-693,373 | $4,915 | $-176,414 | $47,790 |
| Investing Activities | ||||
| Capital Expenditure | $-9,218 | $-9,333 | $-2,530 | $-20,864 |
| Investing Cash Flow | $-9,218 | $-9,333 | $-2,530 | $-20,864 |
| Cash Flow From Continuing Investing Activities | $-9,218 | $-9,333 | $-2,530 | $-20,864 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $66,000 | $0 | - | - |
| Financing Cash Flow | $88,500 | $6,000 | $-27,299 | $-323,600 |
| Cash Flow From Continuing Financing Activities | $88,500 | $6,000 | $-27,299 | $-323,600 |
| Net Common Stock Issuance | $66,000 | $0 | - | - |
| Common Stock Issuance | $66,000 | $0 | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $0 | $-27,299 | $-323,600 |
| Issuance Of Debt | $22,500 | $6,000 | $0 | $0 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $12,631 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $10,336 | $888 | $81,378 | $66,037 |
| Beginning Cash Position | $888 | $81,378 | $66,037 | $35,896 |
| Changes In Cash | $9,448 | $-80,490 | $15,341 | $30,141 |
| Net Issuance Payments Of Debt | $22,500 | $6,000 | $-27,299 | $-323,600 |
| Net Short Term Debt Issuance | $22,500 | $6,000 | $-27,299 | $-323,600 |
| Short Term Debt Payments | $0 | $0 | $-27,299 | $-323,600 |
| Short Term Debt Issuance | $22,500 | $6,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-9,218 | $-9,333 | $-2,530 | - |
| Purchase Of Intangibles | $-9,218 | $-9,333 | $-2,530 | - |
| Change In Working Capital | $1,049,032 | $981,104 | $767,047 | $735,943 |
| Change In Payables And Accrued Expense | $1,046,152 | $979,589 | $787,408 | $737,548 |
| Change In Accrued Expense | $618,463 | $619,774 | $480,753 | $563,382 |
| Change In Interest Payable | $618,463 | $619,774 | $480,753 | $563,382 |
| Change In Payable | $427,689 | $359,815 | $306,655 | $174,166 |
| Change In Account Payable | $420,325 | $388,926 | $306,655 | $174,166 |
| Change In Prepaid Assets | $-1,120 | $1,515 | $-1,370 | $-1,625 |
| Change In Receivables | $4,000 | $0 | $-18,991 | $20 |
| Other Non Cash Items | $119,723 | $1,278,901 | $660,686 | $645,686 |
| Depreciation Amortization Depletion | $20,438 | $18,771 | $18,738 | $17,939 |
| Depreciation And Amortization | $20,438 | $18,771 | $18,738 | $17,939 |
| Gain Loss On Investment Securities | $3,876 | $4,915 | $-32,035 | $157,478 |
| Net Income From Continuing Operations | $-565,654 | $-2,382,440 | $-1,224,887 | $-1,072,753 |
| Changes In Account Receivables | - | $0 | $-18,991 | $7,636 |
| Provisionand Write Offof Assets | - | $21,592 | $0 | - |
| Net Long Term Debt Issuance | - | - | $0 | $-118,400 |
| Long Term Debt Payments | - | - | $0 | $-118,400 |
| Net PPE Purchase And Sale | - | - | $-2,530 | $-20,864 |
| Purchase Of PPE | - | - | $-2,530 | $-20,864 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-02-02